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Abstract
Background: Proper neuronal function requires tight control of gene dosage, and failure of this process underlies
the pathogenesis of multiple neuropsychiatric disorders. The SHANK3 gene encoding core scaffolding proteins at
glutamatergic postsynapse is a typical dosage-sensitive gene, both deletions and duplications of which are
associated with Phelan-McDermid syndrome, autism spectrum disorders, bipolar disorder, intellectual disability, or
schizophrenia. However, the regulatory mechanism of SHANK3 expression in neurons itself is poorly understood.
Results: Here we show post-transcriptional regulation of SHANK3 expression by three microRNAs (miRNAs), miR-7,
miR-34a, and miR-504. Notably, the expression profiles of these miRNAs were previously shown to be altered in
some neuropsychiatric disorders which are also associated with SHANK3 dosage changes. These miRNAs regulated
the expression of SHANK3 and other genes encoding actin-related proteins that interact with Shank3, through
direct binding sites in the 3′ untranslated region (UTR). Moreover, overexpression or inhibition of miR-7 and
miR-504 affected the dendritic spines of the cultured hippocampal neurons in a Shank3-dependent manner.
We further characterized miR-504 as it showed the most significant effect on both SHANK3 expression and
dendritic spines among the three miRNAs. Lentivirus-mediated overexpression of miR-504, which mimics its
reported expression change in postmortem brain tissues of bipolar disorder, decreased endogenous Shank3
protein in cultured hippocampal neurons. We also revealed that miR-504 is expressed in the cortical and
hippocampal regions of human and mouse brains.
Conclusions: Our study provides new insight into the miRNA-mediated regulation of SHANK3 expression, and
its potential implication in multiple neuropsychiatric disorders associated with altered SHANK3 and miRNA
expression profiles.
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Background
Accumulating evidence from both human and animal
model studies suggests that genetic variants are critical
risk factors for various neuropsychiatric disorders [1].
Copy number variations (CNVs), deletions and duplica-
tions, are structural variations in the genome that cause
gene dosage changes. Interestingly, there are some loci
in the human genome, such as 15q11-13, 16p11.2, and
22q13.3, both deletions and duplications in which are as-
sociated with neuropsychiatric disorders [2–4]. This sug-
gests that the correct dosage of some genes within these
loci is critical for normal brain function, and that there
should be some regulatory mechanism in the brain to
tightly control the expression of these dosage-sensitive
genes.
The SHANK3 (also called ProSAP2) gene, which en-
codes for core scaffolding proteins at the postsynaptic
density (PSD) of glutamatergic synapses [5], is a typical
dosage-sensitive gene in chromosome 22q13.3. Deletions
and point mutations of SHANK3 are associated with
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Phelan-McDermid syndrome, autism spectrum disorders
(ASDs), intellectual disability, schizophrenia and bipolar
disorder [6–8]. Moreover, its duplications are linked to
Asperger syndrome, attention deficit hyperactivity dis-
order, schizophrenia and bipolar disorder [9–12]. Recent
cell culture and animal model studies have revealed the
molecular and cellular pathophysiology of the neuro-
psychiatric disorders caused by altered SHANK3 dosage
[12–19]. In contrast, however, the regulatory mechanism
that underpins the tight control of SHANK3 expression
in neurons itself remains largely unknown.
MicroRNAs (miRNAs) are small non-coding RNAs that
bind to the 3′ untranslated regions (3′UTRs) of target
mRNAs and downregulate mRNA expression by reducing
mRNA stability or by inhibiting translation [20]. As crit-
ical post-transcriptional regulators of gene expression,
miRNAs are involved in widespread biological processes
of the nervous system, in both physiological and patho-
logical conditions, including neuronal development, syn-
apse formation and plasticity, and neurodegeneration
[21–24]. Furthermore, recent studies revealed altered
miRNA expression profiles in postmortem brains or blood
samples of patients with various neuropsychiatric disor-
ders, including ASDs, schizophrenia, bipolar disorder and
major depression [25–28]. In many cases, however, the
causative roles of altered miRNA expression in neuro-
psychiatric disorders are not clear, because the key target
genes and neuronal mechanisms affected by the miRNAs
have not been identified. We reasoned that if there are
miRNA target genes mediating pathogenesis, dosage-
sensitive genes involved in neuronal function could be the
most reasonable targets. Therefore, by investigating the
relationship between the miRNAs and dosage-sensitive
genes associated with the same type of neuropsychiatric
disorder, we might gain some insight, not just into the
pathogenesis of the disorder, but also into the miRNA-
mediated regulation of dosage-sensitive genes.
In this study, we examine this possibility for the
SHANK3 gene and report post-transcriptional regulation
of SHANK3 expression by three miRNAs, miR-7, miR-
34a, and miR-504, which were previously shown to be
altered in some neuropsychiatric disorders that could
also be caused by SHANK3 dosage changes. We also
show that these miRNAs regulate neuronal dendritic
spines in a Shank3-dependent manner, which might pro-
vide some insight into the pathogenic mechanisms of
neuropsychiatric disorders with altered miRNA expres-
sion profiles.
Results
miR-7, miR-34a, and miR-504 directly regulate the
expression of SHANK3
Using the TargetScan prediction tool (Release 6.2, http://
www.targetscan.org/vert_61/), we identified ~30 putative
miRNA families that have evolutionarily conserved
binding sites in the human SHANK3 3′UTR (Additional
file 1: Table S1). Following a literature search, we nar-
rowed down this list of miRNAs based on their neuronal
expression, and their expression changes in the neuro-
psychiatric disorders which are also associated with
SHANK3 dosage changes. Finally, we chose three miR-
NAs, miR-7, miR-34a, and miR-504 because of their
strong 8-mer type binding sites [20] in the SHANK3 3′
UTR. The expression of miR-7, miR-34a and miR-504
were reported to be altered in the postmortem brains,
fibroblasts, or blood samples of patients with schizo-
phrenia, depression, or bipolar disorder (Additional
file 1: Table S2) [29–34]. Recently, Zhang et al. claimed
that the miR-7/SHANK3 axis could be involved in schizo-
phrenia pathogenesis, showing an inverse correlation be-
tween the expression levels of miR-7 and SHANK3 [35].
However, neither the direct binding of miR-7 to the
SHANK3 3′UTR nor its functional effect on neuronal
synapses have been reported.
Including poorly conserved binding sites, two to three
binding sites in the SHANK3 3′UTR for each of the
three miRNAs were predicted by TargetScan (Fig. 1a).
To validate these binding sites, we performed luciferase
assays using constructs containing the SHANK3 3′UTR
with or without mutations for the binding sites (Fig. 1b–d).
Expression of miR-7 decreased the luciferase activity of the
wild-type SHANK3 3′UTR construct in HEK293T cells,
indicating that miR-7 inhibited its expression (Fig. 1b).
Between the two putative miR-7 binding sites in the
SHANK3 3′UTR (523–530 and 1, 080–1, 086), muta-
tion of the first (523–530) abolished the effect of miR-7
on luciferase activity (Fig. 1b). Furthermore, the expres-
sion of rat Shank3 3′UTR, where the second miR-7
binding site of human 3′UTR is not conserved, was still
reduced by miR-7 in the luciferase assay (Fig. 1b), indi-
cating that the first site in the SHANK3 3′UTR is the
only functional target site for miR-7. Expression of
miR-34a or miR-504 also decreased the luciferase activ-
ity of the wild-type SHANK3 3′UTR construct in
HEK293T cells (Fig. 1c and d). Additional luciferase as-
says using the SHANK3 3′UTR constructs with single
or multiple mutations in the putative binding sites re-
vealed that each miRNA had a single functional target
site in the SHANK3 3′UTR (549–556 for miR-34a, and
1, 713-1, 720 for miR-504) (Fig. 1c and d).
The validated target sites for miR-7, miR-34a, and
miR-504 were highly conserved across different species
(Fig. 1e). However, the miR-34a target site was not con-
served in mouse and rat, and consistently, the expression
of miR-34a did not affect the luciferase activity of the rat
Shank3 3′UTR construct in HEK293T cells (Fig. 1f ).
When expressed at a fixed total amount, miR-7, miR-34a,
and miR-504 in combination decreased the luciferase
Choi et al. Molecular Brain  (2015) 8:74 Page 2 of 12
activity of SHANK3 3′UTR more efficiently than each
miRNA alone, suggesting their synergistic effect (Fig. 1g).
The three miRNAs, either alone or together, did not
change the mRNA levels of the SHANK3 3′UTR lucifer-
ase construct (Fig. 1h). We also investigated whether the
three miRNAs could regulate the expression of SHANK1
or SHANK2, the two other members in the SHANK gene
family. TargetScan predicted that the SHANK2 3′UTR
contained conserved miR-7, but not miR-34a or miR-504,
binding sites. However, miR-7 did not change the expres-
sion of SHANK2 3′UTR in luciferase assays (Fig. 1i),
which might be, at least partly, due to the difference in the
secondary structures of SHANK3 and SHANK2 3′UTRs
(Additional file 1: Figure S1). Together, these results sug-
gest that miR-7, miR-34a, and miR-504 directly bind to
the SHANK3 3′UTR and downregulate its expression.
Fig. 1 Validation of miR-7, miR-34a, and miR-504 binding sites in the SHANK3 3′UTR by luciferase assays in HEK293T cells. a TargetScan prediction
of the miRNA binding sites in the human SHANK3 3′UTR. The underlines indicate evolutionarily conserved binding sites. b miR-7 decreased the
luciferase activity of the wild-type (hWT), but not the first binding site-mutant (hM), SHANK3 3′UTR. The luciferase activity of the rat Shank3 3′UTR
(rWT), containing only the first binding site, was still reduced by miR-7. RL, Renilla luciferase; FL, firefly luciferase. c Mutation of the second
miR-34a binding site (M2) blocked its repressive effect on the expression of the SHANK3 3′UTR. d Mutation of the second miR-504 binding site
(M2) blocked its repressive effect on the expression of the SHANK3 3′UTR. e The validated functional miRNA binding sites in the SHANK3 3′UTR
(left), and their base-pairings with the three miRNAs (middle). The sequence alignment across species for each miRNA binding site (right). f miR-34a
did not affect the expression of the rat Shank3 3′UTR. g miR-7, miR-34a, and miR-504 synergistically decreased the expression of the SHANK3 3′UTR.
h miR-7, miR-34a, and miR-504 did not affect the mRNA levels of the SHANK3 3′UTR. i miR-7 did not affect the expression of the human SHANK2 3′UTR
that contains two putative miR-7 binding sites. All data are presented as mean ± SEM. Statistical analyses are in Additional file 1: Table S3
Choi et al. Molecular Brain  (2015) 8:74 Page 3 of 12
miR-7, miR-34a, and miR-504 potentially regulate other
targets in the Shank3 interactome
It is not uncommon for a single miRNA to regulate the
expression of multiple proteins participating in the same
pathway or interacting with each other [36]. Previously,
we generated a comprehensive Shank3 protein interac-
tome by combining yeast two-hybrid screening with
mouse brain in vivo immunoprecipitation followed by
mass-spectrometry analysis [12]. Therefore, we searched
for proteins in the Shank3 interactome that might also
be regulated by miR-7, miR-34a, or miR-504.
We first pooled the putative human target genes for
each of the three miRNAs from six prediction tools
(total 8,246 targets for miR-7, 4,635 for miR-34a, and
3,392 for miR-504), and then compared these lists with
338 Shank3 interactome genes [12]. When we picked
those targets suggested by more than two prediction
tools, 79, 67, and 46 genes in the Shank3 interactome
were revealed as putative targets for miR-7, miR-34a,
and miR-504, respectively (Fig. 2a). Gene ontology (GO)
analysis of these genes suggested actin and cytoskeletal
protein binding as the major molecular function (Fig. 2a).
Indeed, many genes in the actin-related subnetwork of
the Shank3 interactome [12] were predicted as putative
targets for the miRNAs (Fig. 2b). To validate these
actin-related targets, we first narrowed the gene list
down to 11 genes (13 gene-miRNA pairs) which were
predicted by more than three different tools. We per-
formed luciferase assays in HEK293T cells with constructs
containing the 3′UTRs of the genes, and found that 6 of
the 13 gene-miRNA pairs showed decreased luciferase ac-
tivity after miRNA overexpression (Fig. 2c). We further
mutated the putative miRNA binding sites in the 3′UTRs
of PFN2 and SPTBN2, the two genes most downregulated
by miR-7 and miR-504, respectively, and found that the
mutations abolished the effect of the miRNAs in the lucif-
erase assays (Fig. 2d and e). The validated target sites in
the PFN2 and SPTBN2 3′UTRs were highly conserved
across different species (Fig. 2f). These results suggest that
miR-7, miR-34a, and miR-504 could also potentially regu-
late the expression of some Shank3-interacting proteins,
especially those involved in actin regulation.
miR-7 and miR-504 regulate dendritic spines of cultured
hippocampal neurons
Based on the results from HEK293T cells, we investi-
gated the roles of the three miRNAs in neurons. We first
repeated the luciferase assays in cultured mouse hippo-
campal neurons by co-transfecting the miRNAs and
luciferase constructs. Consistent with the results from
HEK293T cells (Fig. 1), miR-7, miR-34a, and miR-504
decreased the luciferase activity of the wild-type, but not
the respective binding site-mutant, SHANK3 3′UTR
constructs (Fig. 3a and b).
Shank3 overexpression increases while its knockdown
decreases the number of dendritic spines in cultured
neurons [14, 37]. Thus, we tested whether the miRNAs
targeting SHANK3 3′UTR could also affect dendritic
spines. We transfected enhanced green fluorescent pro-
tein (EGFP)-expressing plasmid with control miRNA,
miR-7, or miR-504 into cultured mouse hippocampal
neurons, and immunostained the neurons with GFP
antibody to visualize dendritic protrusions. We did not
include miR-34a in the experiment because there is no
miR-34a target sequence in the mouse Shank3 3′UTR
(Fig. 1e and f). However, overexpression of miR-34a was
shown to alter dendritic protrusions in cultured mouse
neurons by regulating the expression of other synaptic
proteins [38]. We found that both miR-7 and miR-504
overexpression decreased dendritic spine density, but
neither of the miRNAs affected filopodia (Fig. 3c). To
understand whether the spine changes were due to the
miRNA-mediated decrease in Shank3 expression, we
designed rescue experiments using the full-length rat
Shank3-expressing constructs with or without the 3′
UTR. We reasoned that only the construct without 3′
UTR could rescue the spine phenotype, as it has no
miRNA binding site and thus resistant to miRNA over-
expression. Indeed, in HEK293T cells, miR-7 and miR-
504 reduced the expression of Shank3 proteins from the
construct with the 3′UTR, but did not affect the con-
struct without the 3′UTR (Fig. 3d). We transfected cul-
tured hippocampal neurons with control miRNA, miR-7,
or miR-504 in combination with the two Shank3 con-
structs. When co-transfected with control miRNA,
Shank3 expression, regardless of the presence of the 3′
UTR, caused a significantly higher dendritic spine dens-
ity compared to that observed with EGFP expression
alone (Fig. 3e). However, only the Shank3 construct
without the 3′UTR could rescue the decreased spine
density in response to miR-7 or miR-504 overexpression
(Fig. 3e). Consistently, the expression of Shank3 construct
with 3′UTR, but not that without 3′UTR, was decreased
by miR-7 and miR-504 in cultured neurons measured by
immunostaining (Additional file 1: Figure S2).
As miR-7, miR-34a, and miR-504 are expressed in
mouse hippocampal neurons [39–41], we decided to test
the effect of inhibition of endogenous miRNAs on
SHANK3 expression and dendritic spines. Transfection
of locked-nucleic acid (LNA) inhibitors against each of
the miRNAs increased the luciferase activity of wild-
type, but not the respective binding site-mutant,
SHANK3 3′UTR constructs, suggesting that endogenous
miR-7, miR-34a, and miR-504 could regulate SHANK3
expression (Fig. 3f and g). Moreover, opposite to the
miRNA overexpression, miR-7 or miR-504 inhibition in-
creased spine density in cultured mouse hippocampal
neurons (Fig. 3h). In the case of miR-504 inhibition, the
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density of the filopodia was decreased (Fig. 3h). To
understand whether Shank3 expression was required for
the spine changes observed after miR-7 or miR-504 in-
hibition, we co-transfected a previously validated siRNA
targeting mouse Shank3 [12]. We found that Shank3
siRNA alone resulted in lower spine density compared
to that observed with control siRNA, and that it also
blocked the increase in spine density in response to
miR-7 or miR-504 inhibition (Fig. 3i).
Recently, an endogenous circular RNA that has more
than 70 binding sites for miR-7 was identified [42, 43].
This circular RNA can indirectly increase the expression
of other miR-7 targets by sequestering miR-7, and was
thus named as a circular RNA sponge for miR-7 (ciRS-7)
[42]. Indeed, in HEK293T cells, ciRS-7 expression partially
blocked the inhibitory effect of miR-7 on the luciferase ac-
tivity of the wild-type, but not the miR-7 binding-mutant
SHANK3 3′UTR construct (Fig. 3j). As ciRS-7 and miR-7
were detected in neuronal tissues including the hippo-
campus [42, 43], we examined the effect of ciRS-7 over-
expression on dendritic spines. We found that cultured
hippocampal neurons transfected with ciRS-7 showed
increased spine density compared to the neurons trans-
fected with control plasmid (ciRS-7-ir) (Fig. 3k), which
Fig. 2 Regulation of Shank3-interacting actin-related proteins by miR-7, miR-34a, and miR-504. a Summary of the process identifying putative miR-7,
miR-34a, and miR-504 targets in the Shank3 interactome (top), and the GO analysis of the putative targets (bottom). b Actin-related subnetwork of the
Shank3 interactome with color codes for the putative miRNA targets. c miR-7, miR-34a, and miR-504 decreased the expression of the 3′UTRs of some
Shank3-interacting proteins in luciferase assays. d Mutation of the miR-7 binding site blocked its repressive effect on the expression of the human
PFN2 3′UTR. e Mutation of the miR-504 binding site blocked its repressive effect on the expression of the human SPTBN2 3′UTR. f The sequence
alignments across species for the miR-7 and miR-34a binding sites in the PFN2 and SPTBN2 3′UTRs, respectively. All data are presented as mean ± SEM.
Statistical analyses are in Additional file 1: Table S3
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was the same phenotype as that observed in response to a
miR-7 LNA inhibitor (Fig. 3h). Taken together, these re-
sults suggest that miR-7, miR-34a, and miR-504 could
regulate SHANK3 expression in cultured mouse hippo-
campal neurons, and that miR-7 and miR-504 could regu-
late dendritic spines in a Shank3-dependent manner.
Human and mouse brain expression patterns of miR-504
We decided to further characterize miR-504, as it most
significantly downregulated SHANK3 levels and changed
dendritic spines among the three miRNAs we tested
(Figs. 1 and 3). Notably, expression of miR-504 was
shown to be increased in the dorsolateral prefrontal
Fig. 3 miR-7 and miR-504 regulate dendritic spines of cultured hippocampal neurons in a Shank3-dependent manner. a miR-7, miR-34a, or miR-504
overexpression decreased the luciferase activity of wild-type SHANK3 3′UTR in cultured mouse hippocampal neurons. b miR-7, miR-34a, and miR-504
did not affect the luciferase activity of the mutant SHANK3 3′UTR constructs in cultured neurons. c Overexpression of miR-7 or miR-504 decreased the
density of dendritic spines in cultured mouse hippocampal neurons (n = 16–30). d Representative western blot images show that overexpression of
miR-7 or miR-504 decreased the expression of the rat Shank3 construct with the 3′UTR, but not of that without the 3′UTR, in HEK293T cells. EGFP
expressing plasmid was co-transfected as an internal control. Notably, we observed decreased expression of EGFP when miR-7 was cotransfected.
Nevertheless, after normalization with EGFP, the expression of Shank3 with 3′UTR, but not that without 3′UTR, was significantly decreased by miR-7.
e Co-transfection of the Shank3 construct without the 3′UTR, but not that with the 3′UTR, rescued the decreased dendritic spine density by miR-7 or
miR-504 overexpression (n = 20–30). f LNA-inhibitor against miR-7, miR-34a, or miR-504 increased the expression of co-transfected SHANK3 3′UTR in
cultured mouse hippocampal neurons. g LNA-inhibitor against miR-7, miR-34a, and miR-504 did not affect the expression of the mutant SHANK3 3′UTR
in cultured neurons. h LNA-inhibitor against miR-7 or miR-504 increased dendritic spines in cultured neurons (n = 18–20). i Co-transfection of Shank3
siRNA blocked the increase of dendritic spines in response to miR-7 or miR-504 inhibition (n = 16–20). j ciRS-7 partially blocked the repressive effect of
miR-7 on the expression of wild-type SHANK3 3′UTR in HEK293T cells. Neither miR-7 nor ciRS-7 changed the expression of miR-7 binding-mutant
SHANK3 3′UTR. ciRS-7-ir is a control plasmid that does not express the circular RNA. k Overexpression of ciRS-7 increased dendritic spines in cultured
mouse hippocampal neurons (n = 15–20). Scale bar, 10 μm. All data are presented as mean ± SEM. Statistical analyses are in Additional file 1: Table S3
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cortex from postmortem brains of bipolar disorder [32],
and in the nucleus accumbens in a rat model of depres-
sion induced by maternal deprivation followed by
chronic unpredictable stress [44]. These reports, to-
gether with our results from spine analysis, prompted us
to test the effect of miR-504 overexpression on endogen-
ous Shank3 levels. We used a lentivirus expressing
TurboGFP together with control miRNA or miR-504.
Consistent with our results from the luciferase assays,
infection of the virus expressing miR-504 decreased
Shank3 proteins in cultured hippocampal neurons con-
firmed by western blot experiments (Fig. 4a and b). The
expression of other synaptic proteins, Shank2 and PSD-
95, were not significantly changed by miR-504 (Fig. 4b).
Although miR-504 was detected in some brain regions
including the cortex [32], hippocampus [41], and nu-
cleus accumbens [44], its overall expression pattern in
the brain has not been characterized. To understand
this, we first investigated the regional expression pattern
of miR-504 in human brain by performing bioinformatic
analyses on the developing human brain miRNA se-
quencing data from the BrainSpan database (http://
www.brainspan.org). We found that miR-504 was de-
tected throughout all brain regions, with the highest
median value of reads per million mapped reads
(RPM) found in the hippocampus (HIP), and the low-
est median value found in the cerebellar cortex
(CBC) (Fig. 4c). In terms of the expression rank of
miR-504 among all the 1,883 miRNAs available for
each brain region, the primary somatosensory cortex
(S1C) and cerebellar cortex showed the highest and
lowest values, respectively (Fig. 4c). To directly
visualize miR-504 expression, we next performed in
situ hybridization of miR-504 in the brains of 3- and
8-week-old mice. Similar to the expression pattern in
human brains, strong miR-504 signals were detected
in the cortex and hippocampus from both stages
(Fig. 4d). In the cerebellum, the signal was mainly
detected in the Purkinje cells (Fig. 4d). Together,
these results suggest that the increased expression of
miR-504 observed in postmortem brains of bipolar
disorder and in a rat model of depression, might pos-
sibly lead to a decrease in Shank3 protein in some
brain regions.
Discussion
Fine-tuning of dosage-sensitive SHANK3 should require
tight control of the entire process of gene expression,
from transcription to post-translational modification.
Therefore, it is possible that abnormalities in the regula-
tory processes of SHANK3 expression result in patho-
genic outcomes similar to those observed with genetic
mutations of SHANK3 itself. One such example is the
DNA methylation of SHANK3, which is critical for
tissue-specific control of SHANK3 expression [45–47].
Recently, Zhu et al. found that DNA methylation of the
intragenic CpG islands of SHANK3 was significantly in-
creased in postmortem brain tissues of ASD patients,
which could be associated with altered expression and
alternative splicing of SHANK3 in ASD brains [48]. In
the present study, we tried to propose and test an
additional example by investigating miRNA-dependent
regulation of SHANK3 expression. We found that miR-
7, miR-34a, and miR-504, three miRNAs with altered
expression profiles in multiple neuropsychiatric disor-
ders, directly regulate SHANK3 expression. Moreover,
these miRNAs potentially regulate other targets interact-
ing with Shank3 in actin-regulatory pathway. Consistently,
both gain- and loss-of-function experiments showed
that miR-7 and miR-504 control actin-rich dendritic
spines. Importantly, these dendritic spine changes were
dependent on Shank3, suggesting that Shank3 functions
as a core protein among the actin-related miR-7 and miR-
504 targets in regulating dendritic spines. Together,
our results provide new insight into the miRNA-
mediated regulation of SHANK3 expression, and its
potential implications for multiple neuropsychiatric
disorders with altered expression profiles of miR-7,
miR-34a, and miR-504.
According to the recent study from Wang et al. there
are at least ten Shank3 isoforms from the usage of intra-
genic promoters and alternative splicing [49]. Although
each isoform has brain region- and development-specific
expression pattern, six out of ten major Shank3 isoforms
have sterile alpha motif (SAM) domain at the C-terminus,
which is encoded by the last exon containing the 3′UTR
sequence. Moreover, using 3′-end sequencing and identi-
fying polyA signal hexamers, Epstein et al. showed that
Shank3 3′UTR has only one polyadenylation site, whereas
Shank1 and Shank2 3′UTR could have more than one
polyadenylation sites [50]. Together, these results suggest
that miR-7, miR-34a, and miR-504 could commonly regu-
late the expression of at least six major Shank3 isoforms
(a, a[E10-12S V], c, d, e, and f ) (Additional file 1:
Figure S3) [8, 49]. However, the in vivo effects of
miRNAs on Shank3-related brain function could be
various, because of the specific spatiotemporal expres-
sion of each miRNA. The combinatorial analysis on
the brain expressions of SHANK3 isoforms and the
miRNAs targeting SHANK3 will help us better under-
stand this regulatory process. Furthermore, other tar-
gets of the miRNAs and their roles in synaptic
function need to be more characterized.
Among the three miRNAs, we further characterized
the most potent miR-504. It is tempting to speculate
that increased expression of miR-504 in the prefrontal
cortex of bipolar disorder [32] might contribute to
pathogenesis, at least partly, by downregulating SHANK3
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expression and dendritic spines as we demonstrated in
the cultured hippocampal neurons. Indeed, deletions of
SHANK3 gene have been identified in some patients di-
agnosed with bipolar disorder [51–53]. Bipolar disorder
is a devastating mental illness that causes recurrent
mood swings between depression and mania. Although
the detailed pathophysiology of bipolar disorder remains
largely unknown, both decreased and elevated activity of
the prefrontal cortex have been detected in patients [54],
suggesting that precise control of neuronal activity is
critical for preventing bipolar disorder. Supporting this
idea, we also reported manic-like behavior in the trans-
genic mice overexpressing Shank3 as well as in the pa-
tients with SHANK3 duplications [12, 55]. Therefore,
both deletions and duplications of SHANK3 could be as-
sociated with bipolar disorder by disturbing neuronal
homeostasis.
In addition to SHANK3, miR-504 also regulates the ex-
pression of the dopamine D1 receptor gene (DRD1) [56],
expression or activity of which is associated with mul-
tiple neuropsychiatric disorders including mood disor-
ders [57]. Moreover, maternal deprivation followed by
chronic unpredictable stress increases miR-504 expres-
sion in the rat nucleus accumbens where the miR-504
levels are positively correlated with the severity of
depression-like behavior after stress [44]. These results
suggest that miR-504 might be an important regulator of
gene expression in some cortical and limbic regions as-
sociated with mood disorders, an idea that is also partly
supported by our results for the human and mouse brain
distribution of miR-504. Generation and behavioral
characterization of animal models with altered miR-504
expression in these brain regions could help us test this
intriguing hypothesis.
Fig. 4 Lentiviral overexpression of miR-504 in cultured neurons, and expression analysis of miR-504 in human and mouse brain. a Representative
images of live neurons infected with lentivirus expressing TurboGFP together with miR-504. Scale bar, 100 μm. b Representative western blot
images and quantification showing that lentiviral overexpression of miR-504 decreased endogenous Shank3, but not Shank2 and PSD-95, proteins
in cultured hippocampal neurons. c Box plots showing the expression distribution of miR-504 in 16 human brain regions. The black line in each
box indicates the median value. The lower and upper hinges of each box indicate the lower and upper quartile values, respectively. The whiskers
of each box indicate the most extreme data values within 1.5 times of the interquartile range. The open circles indicate the data values beyond
the whisker limits. The number in parentheses associated with each brain region is the expression rank of miR-504 among all the 1,883 miRNAs
available for the brain region. OFC, orbital prefrontal cortex; DFC, dorsolateral prefrontal cortex; VFC, ventrolateral prefrontal cortex; MFC, medial
prefrontal cortex; M1C, primary motor (M1) cortex; S1C, primary somatosensory (S1) cortex; IPC, posterior inferior parietal cortex; A1C, primary
auditory (A1) cortex; STC, superior temporal cortex; ITC, inferior temporal cortex; V1C, primary visual (V1) cortex; HIP, hippocampus; AMY, amygdala;
STR, striatum; MD, mediodorsal nucleus of the thalamus; CBC, cerebellar cortex. d In situ hybridization of miR-504 in mouse brains. miR-504 signals
were detected in neurons of cortex and hippocampus, and in Purkinje cells of cerebellum from 3- and 8-week-old mice. The probe against scrambled
miRNA (miR-SCR) was used as a negative control. CB, cerebellum; CTX, cortex; DG, dentate gyrus; GL, granular layer; ML, molecular layer; PL, Purkinje cell
layer. Scale bar, 500 μm. All data are presented as mean ± SEM. Statistical analyses are in Additional file 1: Table S3
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Conclusions
In this study, we showed post-transcriptional regulation
of SHANK3 expression in neurons by three miRNAs,
miR-7, miR-34a, and miR-504. We propose that similar
approaches could be applied to other dosage-sensitive
genes and miRNAs commonly associated with some
neuropsychiatric disorders, which could provide new
insights into the molecular basis of pathophysiology,
and potentially into novel diagnostic and therapeutic
approaches.
Methods
Luciferase assay
The 3′UTR regions of human SHANK3 (NM_033517.1,
104-1,815), rat Shank3 (NM_021676.1, 100-1, 853),
and human ABI2 (NM_005759.5, 1-1, 036), ARPC5
(NM_005717.3, 371-1, 184), BAIAP2 (NM_017450.2,
1-602), DBNL (NM_001122956.1, 31-782), DSTN
(NM_001011546.1, 1-703), ITSN1 (NM_001001132.1,
1-897), MAP1A (NM_002373.5, 55-1,386), PFN2
(NM_053024.3, 9-1,506), SHANK2 (NM_012309.3,
948-4,643), SPTBN2 (NM_006946.2, 1-555), SYNPO
(NM_007286.5, 1, 238-2090), andWASF1 (NM_001024934.1,
41-643) were PCR amplified from brain cDNA libraries
and subcloned into the psiCHECK-2 vector (Promega).
Mutagenesis reactions of the 3′UTR constructs were
performed using the QuikChange XL Site-Directed
Mutagenesis Kit (Agilent Technologies) to change the
three nucleotides of the miRNA seed match regions
(position 4 to 6) into complementary sequences.
HEK293T cells in 24-well plates were transfected with
30 ng of psiCHECK-2 construct plus 20 pmol of
miRNA duplex (miRIDIAN Dharmacon) using Lipo-
fectamine 2000 (Invitrogen). To test the effect of a
circular RNA sponge for miR-7, 200 ng of ciRS-7-ir
or ciRS-7 plasmids (kindly gifted from Dr. Jorgen
Kjems) were co-transfected with 30 ng of psiCHECK-
2 SHANK3 3′UTR and 6 pmol of miR-7 duplex. After
24 h, luciferase activities were measured using the
Dual Luciferase Reporter Assay System (Promega).
RNA extraction and quantitative real-time reverse
transcription PCR
Total RNA was extracted from HEK293T cells in 24-
well plates using a miRNeasy minikit (Qiagen) accord-
ing to the manufacturer’s instructions. 1 μg of DNase-
treated total RNA was used to synthesize cDNA using
the Quantitect Reverse Transcription Kit (Qiagen).
Quantitative real-time reverse transcription PCR (qRT-
PCR) experiments were performed using the CFX96
Touch Real-Time PCR Detection System (Bio-Rad
Laboratories) with PerfeCta SYBR Green FastMix, ROX
(Quanta Biosciences). The primers for the qRT-PCR
reactions are as follows:
Renilla luciferase gene forward 5′-CGAAGAGGGCG
AGAAAATGG-3′
reverse 5′-ACTCCTCAGGCTCCAGTTTC-3′
firefly luciferase gene forward 5′-GCATTTCTCAGCC
TACCGTG-3′
reverse 5′-CAGCTTCTTCTGCACGTTCA-3′
Bioinformatics
The secondary structures of SHANK3 and SHANK2 3′
UTRs were predicted by RNAfold (http://rna.tbi.univie.ac.at/
cgi-bin/RNAfold.cgi). To identify the putative miR-7,
miR-34a, and miR-504 targets in the Shank3 interactome,
we first pooled all the putative targets for each miRNA
from six different prediction tools (TargetScan [http://
targetscan.org/], MiRANDA [http://www.microrna.org/
microrna/home.do], PicTar2 [http://pictar.mdc-berlin.de/],
DIANA-microT [http://diana.cslab.ece.ntua.gr/microT/],
miRDB [http://mirdb.org/miRDB/], and EIMMo3 [http://
www.mirz.unibas.ch/ElMMo3/]). These lists (8,246 targets
for miR-7, 4,635 for miR-34a, and 3,392 for miR-504) were
compared with the 388 proteins in the Shank3 interac-
tome. The targets predicted by more than two different
prediction tools were further considered for gene ontology
(GO) analysis using DAVID software (version 6.7)
(https://david.ncifcrf.gov/).
To understand the human brain distribution of miR-
504, the miRNA sequencing data of the developing hu-
man brain were downloaded from the BrainSpan data-
base (http://www.brainspan.org). This dataset contains
216 samples spatially covering 16 brain regions and tem-
porally spanning developmental periods from 4 months
to 23 years of age. Reads were normalized to reads per
million mapped reads (RPM) using the formula:
R ¼ 10
6C
NL
where C is the number of reads mapped to one
miRNA, N is the total number of mapped reads in the
sample, and L is the length of the miRNA. To explore
the regional expression pattern of miR-504, the dataset
was divided into 16 brain regions, with the samples from
the same brain region being grouped together. To obtain
the expression rank of miR-504 among all the 1,883
miRNAs for each brain region, the median value of each
miRNA across all the samples in the brain region was
computed, and the resulting median values of all miR-
NAs were ranked in descending order.
Hippocampal neuron culture, transfection, and
immunostaining
Hippocampal neurons were prepared from postnatal day
1 mice of C57BL/6 J background, and cultured as de-
scribed previously [36]. At 7 days in vitro (DIV 7),
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neurons on each coverslip in 24-well plates were trans-
fected with 200 ng of pEGFP-C1 (Clontech), 30 pmol of
miRNA duplex, and 200 ng of pcDNA3.1 (as filler,
Invitrogen) or HA-Shank3 (with or without 3′UTR)
plasmids using Lipofectamine 2000. For inhibition of en-
dogenous miRNAs, neurons were transfected with
200 ng of pEGFP-C1, and 50 pmol of LNA-inhibitor
(miRCURY EXIQON) or 800 ng of ciRS-7-ir/ciRS-7
plasmids. 30 pmol of Shank3 siRNA (Ambion, s81603)
was co-transfected for the rescue experiments. At DIV
14, transfected neurons were fixed with 4 % formalde-
hyde/4 % sucrose in phosphate-buffered saline (PBS),
and permeabilized with 0.2 % Tx-100 in PBS. PBS with
0.1 % BSA and 3 % horse serum was used for blocking
and antibody incubation. Rabbit GFP (1:500, Abcam,
ab290) and mouse HA (1:300, Santa Cruz) antibodies
were used for immunostaining.
Lentiviral infection of cultured hippocampal neurons
Lentiviral particles expressing TurboGFP together
with the mature form of a control miR (Dharmacon,
S05-005000-01) or miR-504 (shMIMIC Dharmacon,
VSM6213-213638367) under a CAG promoter were ap-
plied to cultured hippocampal neurons (DIV 1, multipli-
city of infection of 5) prepared from embryonic day 18
rats. At DIV 14, neurons were processed for western blot
experiments.
Western blot and antibodies
HEK293T cells were briefly washed with ice-cold PBS
and lysed in RIPA buffer (25 mM Tris–HCl pH 7.6,
150 mM NaCl, 1 % NP-40, 1 % sodium deoxycholate,
0.1 % SDS) with freshly added protease inhibitor cocktail
(Roche). After 20 min incubation on ice, the lysates were
centrifuged at 12,000 g for 20 min. The proteins in the
supernatant were quantified and boiled with Laemmli
sample buffer. For cultured neurons, 2x Laemmli sample
buffer was directly applied after a brief wash with ice-
cold PBS. Rabbit Shank3 (1:1000, Santa Cruz, H-160),
rabbit Shank2 (1:500, #1136) [58], mouse PSD-95
(1:1000, NeuroMab, K28/43), and mouse β-actin (1:5000,
Abcam, ab6276) antibodies were used for western blot
experiments.
In situ hybridization
The 3 and 8 week-old male C57BL/6 mice were deeply
anesthetized, and then perfused with PBS, followed by
4 % paraformaldehyde (PFA) in PBS. Subsequently, iso-
lated brains were post-fixed in 4 % PFA overnight, and
then cryoprotected in 30 % sucrose in PBS. Brains were
sectioned (14 μm thickness) on slide glasses, and then
air-dried. The sections were fixed with 4 % PFA for
20 min and subsequently washed with PBS. The acetyl-
ation reaction (with 0.25 % acetic anhydride in 0.1 M
RNase-free triethanolamine-HCl, pH 8.0) was performed
for 10 min at room temperature (RT). After washing
with PBS, the brain sections were incubated in
hybridization buffer for 2 h at 60 °C, followed by over-
night hybridization with 60 ng/ml DIG-labeled ribop-
robe against miR-504 (Exiqon, 38654-15) at 60 °C. On
the next day, the brain sections were washed with
buffers in the following order: 50 % formamide, 0.2X sa-
line sodium citrate (SSC), PBST (0.1 % Tx-100 in 0.1 M
PBS), 0.2X SSC, and PBST at 60 °C. After blocking with
10 % sheep serum in PBST for 1 h, anti-DIG-AP (1:2000;
Roche) was applied to the brain sections overnight at
RT. After washing with PBST and PBS, brain slices
were incubated in nitro blue tetrazolium/5-bromo-4-
chloro-3-indolyl-phosphate (NBT/BCIP) developing
solution for 8 h to overnight. To stop the reaction,
brain sections were incubated in tap water. After de-
hydration, brain sections were air-dried, incubated
with xylene, and mounted with Permount (Fisher Sci-
entific). Images were acquired with BX53F microscope
(Olympus).
Image acquisition and statistical analysis
For western blot experiments, images were acquired
either with an LAS 4000 (GE Healthcare) or by devel-
oping on films followed by scanning, and quantified
with an ImageJ software package. For immunostaining
of cultured neurons, all z-stack images were acquired
with a LSM780 (Zeiss) confocal microscope under the
same parameter settings, and dendritic protrusions
were analyzed using ImageJ. The dendritic spines were
defined as protrusions with heads, and filopodia were de-
fined as protrusions without head and having a length
at least twice the width. All data were presented as
mean ± SEM. Statistical significance was determined
by Student’s t-test or one-way ANOVA with post hoc
Tukey’s multiple comparisons using GraphPad Prism
6. *P < 0.05, **P < 0.01, ***P < 0.001.
Additional file
Additional file 1: Table S1. The putative miRNA families targeting the
SHANK3 3′UTR predicted by TargetScan (release 6.2). The number of
binding sites for each miRNA family, and the binding type (8mer, 7mer-m8,
or 7mer-1A) are described. Table S2. Altered expression profiles of miR-7,
miR-34a, and miR-504 in multiple neuropsychiatric disorders. Table S3.
Summary of statistical analyses for the experiments. Figure S1. The secondary
structures of SHANK3 (a) and SHANK2 (b) 3′UTRs predicted by RNAfold
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) according to the minimum free
energy. The color code represents base-pair probabilities. Figure S2.
The expression of Shank3 construct with 3′UTR, but not that without
3′UTR, was significantly decreased by miR-7 and miR-504 in mouse
cultured neurons. Statistical analyses are in Additional file 1: Table S3.
Figure S3. The ten major Shank3 isoforms (Wang et al. Molecular
Autism 2014, 5:30) (a), and the nucleotide sequence of the last exon
(exon 22) of Shank3 gene (b). The Shank3 isoforms containing SAM
domain at the C-terminus are labeled with red color. (DOCX 3382 kb)
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